«China-Italy Innovation Expo» on December 15th

«China-Italy Innovation Expo» on December 15th

As part of its commitment to promoting scientific and technological dialogue and cooperation in Campania and Chinese innovation systems, Idis City Science Foundation in cooperation with its partners ZOSP-Zhongguancun Overseas Science Parkto organize China-Italy Innovation Fairan online event scheduled to take place from 9:00 to 11:00, during which 8 companies already selected from among research institutes, startups and innovative companies (4 for each country), will present through presentation sessions, technologies or projects projects in the advanced manufacturing sector.

on the Chinese side China-Italy Innovation Fair Promoted by Beijing Science and Technology Association and organized by ZOSP-Zhongguancun Overseas Science Park. In Italy, it is organized by the IDIS-Città della Scienza Foundation as part of the regional strategic project MAanifattura Campania. The exhibition aims to promote regional research and innovation systems in technology fields that enable transition 4.0 such as high-performance computing, cloud computing, cybersecurity, artificial intelligence, smart sensing, Internet of Things, advanced manufacturing and business models in order to participate in the design, development and manufacture of innovative products and services in the respective markets in the following application areas :

1. Intelligent robotics, Internet of Things and industrial automation solutions;
2. Intelligent driving systems to monitor infrastructure and lands.
3. Innovative solutions for connected vehicles, LiDAR sensors and application systems for intelligent mobility; 4. Advanced technological services to support the transformation 4.0 of SMEs and PA (intersectoral theme for the areas of specialization in RIS3 Campania).
The eight companies that will present themselves are: Tecno In SpA; K-City Srl; Smart Sensing Srl; Inismaros. TimeRiver Technology Co., Ltd. Beijing Jiaxun Feihong Electrical Co., Ltd. intelligence of Liang Dao; AI-Link.

See also  A drug that prolongs the survival of 67% of patients

Leave a Reply

Your email address will not be published. Required fields are marked *